Your Trusted Brand for Over 35 Years

Carpal Tunnel Syndrome References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Chung KC. Commentary: Severe carpal tunnel syndrome. J Hand Surg [Am] . 2003 Jul;28(4):645–6.
  2. Pritsch T, Rosenblatt Y, et al. [Carpal tunnel syndrome]. Harefuah . 2004 Oct;143(10):743–8, 765, 764.Review.
  3. Kuhn MA, Wang X, et al. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren's affected palmar fascia. J Surg Res . 2002 Apr;103(2):146–52.
  4. Bland JD. Carpal tunnel syndrome. Curr Opin Neurol . 2005 Oct;18(5):581–5.
  5. Hirata H, Nagakura T, et al. The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. J Pathol . 2004 Dec;204(5):605–12.
  6. Freeland AE, Tucci MA, et al. Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery . 2002;22(8):378–85.
  7. Tucci MA, Barbieri RA, et al. Biochemical and histological analysis of the flexor tenosynovium in patients with carpal tunnel syndrome. Biomed Sci Instrum . 1997;33:246–51.
  8. Alford JW, Weiss AP, et al. The familial incidence of carpal tunnel syndrome in patients with unilateral and bilateral disease. Am J Orthop . 2004 Aug;33(8):397–400.
  9. Armstrong TJ, Castelli WA , et al. Some histological changes in carpal tunnel contents and their biomechanical implications. J Occup Med . 1984 Mar;26(3):197–201.
  10. Werner RA, Armstrong TJ. Carpal tunnel syndrome: Ergonomic risk factors and intra carpal canal pressure, carpal tunnel syndrome. Phys Med Rehabil Clin N Am . 1997;8(3):555–69.
  11. Werner RA, Andary M. Carpal tunnel syndrome: Pathophysiology and clinical neurophysiology. Clin Neurophysiol . 2002 Sep;113(9):1373–81.
  12. Atisook R, Benjapibal M, et al. Carpal tunnel syndrome during pregnancy: Prevalence and blood level of pyridoxine. J Med Assoc Thai . 1995 Aug;78(8):410–4.
  13. Smith ER. It's all in the wrist: Carpal tunnel syndrome. Rehab Manag . 2003 Aug;16(7):26–7, 68.
  14. Schiavon F, Circhetta C, et al. [The diabetic hand]. Reumatismo . 2004 Jul;56(3):139–42.
  15. Wilson JK, Sevier TL. A review of treatment for carpal tunnel syndrome. Disabil Rehabil . 2003 Feb 4;25(3):113–9. Review.
  16. Chang MH, Chiang HT, et al. Oral drug of choice in carpal tunnel syndrome. Neurology . 1998 Aug;51(2):390–3.
  17. Wong SM, Hui AC, et al. Single vs. two steroid injections for carpal tunnel syndrome: A randomised clinical trial. Int J Clin Pract . 2005 Dec;59(12):1417–21.
  18. Dammers JW, Roos Y, et al. Injection with methylprednisolone in patients with the carpal tunnel syndrome: A randomised double blind trial testing three different doses. J Neurol . 2005 Dec 15.
  19. Branco K, Naeser MA. Carpal tunnel syndrome: Clinical outcome after low-level laser acupuncture, microamps transcutaneous electrical nerve stimulation, and other alternative therapies: An open protocol study. J Altern Complement Med . 1999 Feb;5(1):5–26.
  20. Morse LH. Repetitive motion musculoskeletal problems in the microelectronics industry. Occup Med . 1986 Jan-Mar;1(1):167–74. Review.
  21. Aufiero E, Stitik TP, et al. Pyridoxine hydrochloride treatment of carpal tunnel syndrome: A review. Nutr Rev . 2004 Mar;62(3):96–104. Review.
  22. Jurna I. [Analgesic and analgesia-potentiating action of B vitamins]. Schmerz . 1998 Apr 20;12(2):136–41.
  23. Holm G, Moody LE. Carpal tunnel syndrome: Current theory, treatment, and the use of B6. J Am Acad Nurse Pract . 2003 Jan;15(1):18–22. Review.
  24. Folkers K, Wolaniuk A, et al. Enzymology of the response of the carpal tunnel syndrome to riboflavin and to combined riboflavin and pyridoxine. Proc Natl Acad Sci U S A . 1984 Nov;81(22):7076–8.
  25. Esch PM, Gerngross H, et al. [Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase: A prospective study]. Fortschr Med . 1989 Feb 10;107(4):67 – 8, 71 – 2.
  26. Panagariya A, Sharma AK . A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome. J Assoc Physicians India . 1999 Dec;47(12):1170–2.
  27. Babcock TA, Dekoj T, et al. Experimental studies defining omega-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes. Nutr Clin Pract . 2005 Feb;20(1):62–74. Review.
  28. Nielsen AA, Jorgensen LG, et al. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther . 2005 Dec;22(11–12):1121–8.
  29. Miggiano GA , Gagliardi L. [Diet, nutrition and rheumatoid arthritis]. Clin Ter . 2005 May-Jun;156(3):115–23. Review.
  30. Sud V, Freeland AE. Biochemistry of carpal tunnel syndrome. Microsurgery . 2005;25(1):44–6. Review.
  31. Bengmark S. Curcumin, an atoxic antioxidant and natural NF{kappa}B, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr . 2006 Jan-Feb;30(1):45–51.
  32. Zhou HL, Deng YM, et al. The modulatory effects of the volatile oil of ginger on the cellular immune response in vitro and in vivo in mice. J Ethnopharmacol . 2005 Dec 7. [Epub ahead of print]
  33. Grzanna R, Lindmark L, et al. Ginger: An herbal medicinal product with broad anti-inflammatory actions. J Med Food . 2005 summer;8(2):125–32. Review.
  34. Phan PV, Sohrabi A, et al. Ginger extract components suppress induction of chemokine expression in human synoviocytes. J Altern Complement Med . 2005 Feb;11(1):149–54.
  35. Frondoza CG, Sohrabi A, et al. An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell Dev Biol Anim . 2004 Mar-Apr;40(3–4):95–101.